WallStreetZenWallStreetZen

NASDAQ: MBOT
Microbot Medical Inc Stock

$3.34+0.17 (+5.36%)
Updated Feb 3, 2023
MBOT Price
$3.34
Fair Value Price
$3.95
Market Cap
$26.35M
52 Week Low
$2.97
52 Week High
$6.77
P/E
-1.7x
P/B
4.76x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$14.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.34
Operating Cash Flow
-$12M
Beta
0.85
Next Earnings
Mar 29, 2023
Ex-Dividend
N/A
Next Dividend
N/A

MBOT Overview

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MBOT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MBOT ($3.34) is undervalued by 15.43% relative to our estimate of its Fair Value price of $3.95 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MBOT ($3.34) is not significantly undervalued (15.43%) relative to our estimate of its Fair Value price of $3.95 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MBOT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MBOT due diligence checks available for Premium users.

Be the first to know about important MBOT news, forecast changes, insider trades & much more!

MBOT News

Valuation

MBOT fair value

Fair Value of MBOT stock based on Discounted Cash Flow (DCF)
Price
$3.34
Fair Value
$3.95
Undervalued by
15.43%
MBOT ($3.34) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MBOT ($3.34) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MBOT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MBOT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.7x
Industry
-101.35x
Market
15.09x

MBOT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.76x
Industry
3.71x
MBOT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MBOT's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.5M
Profit Margin
0%
MBOT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$7.4M
Liabilities
$1.9M
Debt to equity
0.34
MBOT's short-term assets ($6.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MBOT's short-term assets ($6.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MBOT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MBOT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.0M
Investing
-$5.0k
Financing
$0.0
MBOT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MBOT vs Medical Stocks

TickerMarket Cap1d %P/EP/B
MBOT$26.35M+5.36%-1.70x4.76x
ECOR$26.41M+0.27%-1.20x1.19x
EKSO$22.34M0.00%-1.48x0.78x
GCTK$19.19M+0.32%-4.28x8.15x
LUCY$16.95M-4.13%N/A3.05x

Microbot Medical Stock FAQ

What is Microbot Medical's quote symbol?

NASDAQ: MBOT) Microbot Medical trades on the NASDAQ under the ticker symbol MBOT. Microbot Medical stock quotes can also be displayed as NASDAQ: MBOT.

If you're new to stock investing, here's how to buy Microbot Medical stock.

What is the 52 week high and low for Microbot Medical (NASDAQ: MBOT)?

(NASDAQ: MBOT) Microbot Medical's 52-week high was $6.77, and its 52-week low was $2.97. It is currently -50.66% from its 52-week high and 12.46% from its 52-week low.

How much is Microbot Medical stock worth today?

(NASDAQ: MBOT) Microbot Medical currently has 7,890,628 outstanding shares. With Microbot Medical stock trading at $3.34 per share, the total value of Microbot Medical stock (market capitalization) is $26.35M.

Microbot Medical stock was originally listed at a price of $64,800.09 in Dec 31, 1997. If you had invested in Microbot Medical stock at $64,800.09, your return over the last 25 years would have been -99.99%, for an annualized return of -32.63% (not including any dividends or dividend reinvestments).

How much is Microbot Medical's stock price per share?

(NASDAQ: MBOT) Microbot Medical stock price per share is $3.34 today (as of Feb 3, 2023).

What is Microbot Medical's Market Cap?

(NASDAQ: MBOT) Microbot Medical's market cap is $26.35M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Microbot Medical's market cap is calculated by multiplying MBOT's current stock price of $3.34 by MBOT's total outstanding shares of 7,890,628.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.